Edelman
Astellas appoints comms head from Baxter
September 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris
Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …
Edelman buys Elan to ‘challenge’ the French PR industry
September 5, 2014Medical Communications, Sales and Marketing Edelman, Elan, publicis
Edelman has swooped in on fellow PR firm Elan to create a ‘new player’ in the communications industry in France. …
Edelman appoints new head of Health Public Affairs
October 17, 2012Medical Communications, Sales and Marketing Camilla Horwood, Edelman
Edelman the world’s largest PR firm has appointed Camilla Horwood to a new role as UK head of Health Public …
Edelman acquires Dutch firm Hinfelaar
October 15, 2010Medical Communications Edelman, Hinfelaar
Edelman has acquired leading Dutch PR agency Hinfelaar to strengthen its position as one of the largest agencies in the …
Edelman bags the FT’s Stefan Stern
May 27, 2010Medical Communications Edelman, appointment, medical communications
PR agency Edelman has appointed Stefan Stern director of strategy.He will provide senior counsel to the agency’s clients across all …
Edelman appoints Kajsa Wilhelmsson
April 8, 2010Medical Communications Edelman, appointment, medical communications
Kajsa Wilhelmsson has joined Edelman’s health practice as director of European health public affairs. She will be based in the …
Edelman wins AstraZeneca oncology account
November 24, 2009Medical Communications AZ, Edelman
AstraZeneca has handed global PR responsibility for its oncology brands to communications agency Edelman. The deal includes the pharma company’s …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
